| NCT ID | NCT07613333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Carroll University |
| Condition | Postpartum |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-02-19 |
| Primary Completion | 2028-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-02-19 with a primary completion date of 2028-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The postpartum period is associated with decreases in physical activity levels, muscular strength, muscular endurance, and pelvic floor muscle function, but little scientific evidence exists on how best to initiate and progress exercise in the postpartum period. This proposal aims to improve habitual physical activity levels, neuromuscular health (i.e., strength, fatigability, symptom burden) and overall wellbeing (i.e., decreased fear of movement, improved sleep quality, improved perception of quality of life) through participation in a weekly exercise program. This study will help to inform postpartum exercise recommendations and is novel as it allows participants to incorporate their children into the exercise routine, thus removing a primary barrier to physical activity/exercise.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * gave birth in the 24 months prior to study enrollment Exclusion Criteria: * less than 6 weeks postpartum or not medically appropriate to engage in exercise regardless of time since childbirth (will be screened using the Get Active Questionnaire for Postpartum) * prescription anti-inflammatory/pain medications that are taken daily; * significant orthopedic conditions that would contraindicate performance of the fatigue task and participation in the exercise intervention (such as fractures, severe scoliosis, etc) * moderate to severe cardiovascular \&/or pulmonary disease that contraindicates participation in exercise * neuromuscular health conditions (such as diabetes, neuropathy, multiple sclerosis, stroke, seizures, etc); * smoking/vaping or use of other tobacco or nicotine products (chewing tobacco, nicotine patches, nicotine gum, etc.) * use of any illegal drugs
Contact & Investigator
Rita Deering, DPT, PhD
PRINCIPAL INVESTIGATOR
Carroll University
Frequently Asked Questions
Who can join the NCT07613333 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07613333 currently recruiting?
Yes, NCT07613333 is actively recruiting participants. Contact the research team at deeringresearch@carrollu.edu for enrollment information.
Where is the NCT07613333 trial being conducted?
This trial is being conducted at Waukesha, United States.
Who is sponsoring the NCT07613333 clinical trial?
NCT07613333 is sponsored by Carroll University. The principal investigator is Rita Deering, DPT, PhD at Carroll University. The trial plans to enroll 50 participants.